HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Veronate

antibody-based immunotherapy for the potential prevention of Staphylococcus epidermidis, Staphylococcus aureus and Candida infections in very-low-birth-weight infants; In Phase III clinical trial 2/2006
Also Known As:
INH-A00021; INH-A21
Networked: 7 relevant articles (3 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Roberson, Destrey: 2 articles (09/2007 - 10/2005)
2. Kesler, Karen: 2 articles (09/2007 - 10/2005)
3. Jung, Elizabeth: 2 articles (09/2007 - 10/2005)
4. Schelonka, Robert: 2 articles (09/2007 - 10/2005)
5. Hetherington, Seth: 2 articles (09/2007 - 10/2005)
6. Walker, Whit: 2 articles (09/2007 - 10/2005)
7. Bloom, Barry: 2 articles (09/2007 - 10/2005)
8. Bloom, Barry T: 2 articles (06/2006 - 10/2005)
9. Kaufman, David: 2 articles (02/2006 - 10/2005)
10. Patti, Joseph: 2 articles (10/2005 - 10/2005)

Related Diseases

1. Infection
2. Endocarditis
3. Cross Infection (Nosocomial Infection)
4. Sepsis (Septicemia)
5. Staphylococcal Infections

Related Drugs and Biologics

1. Immunoglobulins (Immunoglobulin)
2. Veronate
3. Intravenous Immunoglobulins (IVIG)
4. Monoclonal Antibodies
5. altastaph

Related Therapies and Procedures

1. Catheters
2. Intravenous Infusions
3. Immunotherapy